MPS Pharma Ltd

MPS Pharma Board Meeting Date

MPS Pharmaa will hold a board meeting on 13 November 2026. The meeting will consider unaudited standalone results for the half year ended September 2026.

Advik Laboratories Other Announcement

MPS Pharmaa Limited filed its quarterly statement of investor complaints for the quarter ended 30th September, 2026, reporting NIL complaints.

MPS Pharma Management Change

MPS Pharmaa Limited announced the appointment of Anchal Goyal as an Independent Director for a five-year term. The company also re-appointed Ram Niwas Sharma and statutory auditors Nemani Garg Agarwal & Co.

Advik Laboratories Annual General Meeting

MPS Pharmaa Limited held its 32nd Annual General Meeting on September 29, 2026. Shareholders transacted business including the adoption of audited financial statements and director appointments.

Advik Laboratories Other Announcement

MPS Pharmaa Limited announced the availability of its FY 2025-26 Annual Report on its website. It also requested shareholders to update their KYC and PAN details.

Advik Laboratories Annual General Meeting

The company submitted its 32nd Annual Report and AGM notice for FY 2025-26. The meeting is scheduled for September 29, 2026.

Advik Laboratories Board Meeting Outcome

MPS Pharmaa Ltd announced the outcome of its board meeting, fixing the 32nd AGM date and recommending new director and auditor appointments for shareholder approval.

Advik Laboratories Board Meeting Date

MPS Pharmaa Limited has scheduled a board meeting on September 02, 2026, to consider the notice for the company's upcoming Annual General Meeting.

Advik Laboratories Q1 FY27 Results: Net Loss of ₹0.2 Cr, Loss Widens

Advik Laboratories Ltd reported a net loss of ₹0.2 Cr for Q1 FY27.

Key figure

Net loss ₹0.2 Cr

Advik Laboratories Board Meeting Date

MPS Pharmaa Limited will hold a board meeting on August 13, 2026, to consider and approve the company's un-audited financial results for the quarter ending June 30, 2026.

Advik Laboratories Other Announcement

Advik Laboratories Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing provides the distribution of shares among promoters and public shareholders.

Advik Laboratories Other Announcement

MPS Pharmaa Limited filed its Annual Secretarial Compliance Report for the financial year ended March 2026. The report details governance compliance and historical listing fee defaults.

Advik Laboratories Q4 FY26 Results: Net Loss of ₹0.4 Cr, Loss Widens

Advik Laboratories Ltd reported a net loss of ₹0.4 Cr for Q4 FY26.

Key figure

Net loss ₹0.4 Cr

Advik Laboratories Financial Results

Advik Laboratories reported FY2026 audited financial results alongside the reappointment of internal auditors. The company continues to navigate operational challenges with a qualified audit opinion.

Advik Laboratories Board Meeting Date

MPS Pharmaa Limited scheduled a Board Meeting on May 28, 2026, to approve FY26 audited financial results. The trading window remains closed until May 30, 2026.